Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 10:00:04 pm
46.01 USD   -2.75%
2014Amid Alibaba fever, reasons for caution in IPO market
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about ULTRAGENYX PHARMACEUTICAL
12/06Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™..
GL
11/14ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
11/12ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
11/09ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
11/05ULTRAGENYX : 3Q Earnings Snapshot
AQ
11/05Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update
GL
11/01Lilly buys Siga's Priority Review voucher gained via smallpox approval
AQ
10/30Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results a..
GL
10/29ULTRAGENYX PHARMACEUTICAL : Announces Negative Topline Results from Phase 3 Stud..
AQ
10/29ULTRAGENYX PHARMACEUTICAL : UX007 fails Phase III in glucose transporter disorde..
AQ
10/26Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in ..
GL
10/23ULTRAGENYX PHARMACEUTICAL : Announces Exclusive License to REGENXBIO AAV Vectors..
AQ
10/22Ultragenyx Announces Exclusive License to REGENXBIO AAV Vectors to Develop Ge..
GL
10/19ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Brazil for the Tre..
AQ
10/18Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazi..
GL
10/09FDA, EMA to review Novartis' siponimod for secondary progressive MS
AQ
10/01ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
09/27Ultragenyx Announces Positive Topline Cohort 2 Results from Phase 1/2 Clinica..
GL
09/26ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
09/19ULTRAGENYX PHARMACEUTICAL : Expands Leadership Team and Appoints Dr. Wladimir Ho..
AQ
09/17Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chi..
GL
08/30Ultragenyx to Present at Upcoming Investor Conferences
GL
08/30ULTRAGENYX PHARMACEUTICAL : FDA clarifies path to submission for Ultragenyx's ra..
AQ
08/29ULTRAGENYX PHARMACEUTICAL : Announces FDA Accepts Proposal to Submit an NDA for ..
AQ
08/28ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Europe for the Tre..
AQ
08/27Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europ..
GL
08/03ULTRAGENYX : 2Q Earnings Snapshot
AQ
08/02Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
GL
07/31ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Second Quarter 2018 Fina..
AQ
07/27Ultragenyx to Host Conference Call for Second Quarter 2018 Financial Results ..
GL
07/26ULTRAGENYX PHARMACEUTICAL : Announces First Patient Dosed in Phase 1/2 study of ..
AQ
07/04ULTRAGENYX PHARMACEUTICAL : Announces Positive CHMP Opinion for Mepsevii for the..
AQ
07/02CHMP backs CAR Ts, Orphan candidates
AQ
06/29Ultragenyx Announces Positive CHMP Opinion for Mepsevii™ (vestronidase ..
GL
06/04ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
05/24Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
AQ
05/23Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
GL
05/22Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results
AQ
05/21Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrati..
AQ
05/17Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrati..
GL
05/11Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the..
AQ
05/11ULTRAGENYX PHARMACEUTICAL : Reports First Quarter 2018 Financial Results and Cor..
AQ
05/07ULTRAGENYX : 1Q Earnings Snapshot
AQ
05/07Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update
GL
05/04ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for First Quarter 2018 Finan..
AQ
05/03Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the..
AQ
05/01Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results a..
GL
04/30Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched i..
GL
04/23Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug ..
GL
04/17Ultragenyx and Kyowa Kirin Announce FDA Approval of Crysvita® (burosumab-twza..
GL
03/08Ultragenyx to Present at Upcoming Investor Conferences
GL
03/07ULTRAGENYX PHARMACEUTICAL : Announces Positive Topline Results and DMC Review fr..
AQ
02/26Kyowa Kirin and Ultragenyx Announce Crysvita Receives Conditional Marketing A..
AQ
02/26XLH therapy burosumab gains EU approval
AQ
02/23Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditiona..
GL
02/20ULTRAGENYX PHARMACEUTICAL : reports 4Q loss
AQ
02/20Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Co..
GL
02/16ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Fourth Quarter and Full ..
AQ
02/14ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Fourth Quarter and Full ..
PU
02/14Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2017 Fin..
GL
02/08Ultragenyx to Present at Leerink Partners Global Healthcare Conference
GL
02/01ULTRAGENYX PHARMACEUTICAL : Appoints Camille L. Bedrosian, M.D. as Chief Medical..
AQ
01/29Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and E..
GL
01/24Ultragenyx Announces Pricing of Public Offering of Common Stock
GL
01/22Ultragenyx Announces Proposed Public Offering of Common Stock
GL
01/08NEWMAN FERRARA LLP : Announces Corporate Governance Investigation of Ultragenyx ..
BU
01/07ULTRAGENYX PHARMACEUTICAL : Announces Positive Interim Topline Results From Firs..
PU
01/07Ultragenyx Announces Positive Interim Topline Results From First Cohort of Ph..
GL
01/04Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty ..
GL
01/04Ultragenyx to Present at J.P. Morgan Healthcare Conference
GL
2017ULTRAGENYX PHARMACEUTICAL : Sells Priority Review Voucher for $130 million
AQ
2017Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion ..
AQ
2017ULTRAGENYX PHARMACEUTICAL : Novartis buying Ultragenyx's Priority Review voucher
AQ
2017Ultragenyx Sells Priority Review Voucher for $130 million
GL
2017Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion ..
GL
1  2  3Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL